Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

Menu

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
My View
Tags:

VaxGen AIDSVAX BLA Slated For 2004 While Manufacturing Work Is Finished

  • News

Executive Summary

VaxGen is pushing back its BLA filing for the AIDS vaccine AIDSVAX until 2004 while it works to fulfill pre-approval manufacturing requirements

You may also be interested in...



VaxGen AIDSVAX Hopes Hinge On Positive Finding In Small Subgroups

VaxGen is pinning its hopes for the continued development of AIDSVAX on a positive finding in a small subgroup of black and Asian HIV patients after disappointing Phase III efficacy results in the general high-risk HIV population

VaxGen AIDSVAX Hopes Hinge On Positive Finding In Small Subgroups

VaxGen is pinning its hopes for the continued development of AIDSVAX on a positive finding in a small subgroup of black and Asian HIV patients after disappointing Phase III efficacy results in the general high-risk HIV population

VaxGen IPO Could Allow For Completion of AIDS Vaccine Phase III Trials

VaxGen plans to meet the 2002 deadline for an AIDS vaccine NDA submission set by marketing partner Genentech with the help of an initial public offering of 3.1 mil. shares.

Table

View full table

Tags:
Latest Headlines

Japan Regulatory Update: Revised Law Widens RWD Scope, Price Revisions/Listings

China’s Public Payer Wants To Define Innovative Drugs As Those With ‘Novel Benefits’

Change Is Constant For Pneumococcal Vaccines: US CDC Prepares For Merck’s V116

Woodcock Takes On Rare Disease Challenges In Retirement, Keeps FDA, Industry At Arm’s Length

See All
UsernamePublicRestriction

Register

PS040138

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By